HJ Research delivers in-depth insights on the global Psoriasis market in its upcoming report titled, Global Psoriasis Market Report 2018-2029. According to this study, the global Psoriasis market is estimated to be valued at XX Million US$ in 2023 and is projected to reach XX Million US$ by 2029, expanding at a CAGR of XX% during the forecast period. The report on Psoriasis market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, industrial chain, etc.
This report studies the Psoriasis market status and outlook of global and major regions, from angles of players, countries, product types and end industries, this report analyzes the top players in global Psoriasis industry, and splits by product type and applications/end industries. This report also includes the impact of COVID-19 on the Psoriasis industry.
Global Psoriasis market: competitive landscape analysis
This report contains the major manufacturers analysis of the global Psoriasis industry. By understanding the operations of these manufacturers (revenue and gross margin from 2018 to 2023), the reader can understand the strategies and collaborations that the manufacturers are focusing on combat competition in the market.
Global Psoriasis market: types and end industries analysis
The research report includes specific segments such as end industries and product types of Psoriasis. The report provides market size for each type and end industry from 2018 to 2023. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Global Psoriasis market: regional analysis
Geographically, this report is segmented into several key countries, with market size, growth rate of Psoriasis in these countries from 2018 to 2023, which covering United States, Canada, Germany, France, UK, Italy, Russia, Spain, Netherlands, China, Japan, Korea, India, Australia, Indonesia, Vietnam, Turkey, Saudi Arabia, South Africa, Egypt, Brazil, Mexico, Argentina, Colombia.
Key players in global Psoriasis market include:
AbbVie
Amgen
Johnson & Johnson
Novartis
Eli Lilly & Company
AstraZeneca
Celgene Corporation
UCB
Merck
Market segmentation, by product types:
Tumor Necrosis Factor Inhibitor
Interleukin Inhibitors
Others
Market segmentation, by applications:
Topicals
Systemic
Biologics
1 Industry Overview of Psoriasis
1.1 Research Scope
1.2 Market Segmentation by Types of Psoriasis
1.3 Market Segmentation by End Users of Psoriasis
1.4 Market Dynamics Analysis of Psoriasis
1.4.1 Market Drivers
1.4.2 Market Challenges
1.4.3 Market Opportunities
1.4.4 Porter’s Five Forces
2 Major Manufacturers Analysis of Psoriasis Industry
2.1 AbbVie
2.1.1 Company Overview
2.1.2 Main Products and Specifications
2.1.3 Psoriasis Revenue and Gross Margin (2018-2023)
2.1.4 Contact Information
2.2 Amgen
2.2.1 Company Overview
2.2.2 Main Products and Specifications
2.2.3 Psoriasis Revenue and Gross Margin (2018-2023)
2.2.4 Contact Information
2.3 Johnson & Johnson
2.3.1 Company Overview
2.3.2 Main Products and Specifications
2.3.3 Psoriasis Revenue and Gross Margin (2018-2023)
2.3.4 Contact Information
2.4 Novartis
2.4.1 Company Overview
2.4.2 Main Products and Specifications
2.4.3 Psoriasis Revenue and Gross Margin (2018-2023)
2.4.4 Contact Information
2.5 Eli Lilly & Company
2.5.1 Company Overview
2.5.2 Main Products and Specifications
2.5.3 Psoriasis Revenue and Gross Margin (2018-2023)
2.5.4 Contact Information
2.6 AstraZeneca
2.6.1 Company Overview
2.6.2 Main Products and Specifications
2.6.3 Psoriasis Revenue and Gross Margin (2018-2023)
2.6.4 Contact Information
2.7 Celgene Corporation
2.7.1 Company Overview
2.7.2 Main Products and Specifications
2.7.3 Psoriasis Revenue and Gross Margin (2018-2023)
2.7.4 Contact Information
2.8 UCB
2.8.1 Company Overview
2.8.2 Main Products and Specifications
2.8.3 Psoriasis Revenue and Gross Margin (2018-2023)
2.8.4 Contact Information
2.9 Merck
2.9.1 Company Overview
2.9.2 Main Products and Specifications
2.9.3 Psoriasis Revenue and Gross Margin (2018-2023)
2.9.4 Contact Information
3 Global Psoriasis Market Analysis by Regions, Manufacturers, Types and End Users
3.1 Global Sales Revenue of Psoriasis by Regions (2018-2023)
3.2 Global Sales Revenue of Psoriasis by Manufacturers (2018-2023)
3.3 Global Sales Revenue of Psoriasis by Types (2018-2023)
3.4 Global Sales Revenue of Psoriasis by End Users (2018-2023)
4 Northern America Psoriasis Market Analysis by Countries, Types and End Users
4.1 Northern America Psoriasis Sales Revenue Analysis by Countries (2018-2023)
4.2 Northern America Psoriasis Sales Revenue Analysis by Types (2018-2023)
4.3 Northern America Psoriasis Sales Revenue Analysis by End Users (2018-2023)
4.4 United States Psoriasis Sales Revenue Analysis (2018-2023)
4.5 Canada Psoriasis Sales Revenue Analysis (2018-2023)
5 Europe Psoriasis Market Analysis by Countries, Types and End Users
5.1 Europe Psoriasis Sales Revenue Analysis by Countries (2018-2023)
5.2 Europe Psoriasis Sales Revenue Analysis by Types (2018-2023)
5.3 Europe Psoriasis Sales Revenue Analysis by End Users (2018-2023)
5.4 Germany Psoriasis Sales Revenue Analysis (2018-2023)
5.5 France Psoriasis Sales Revenue Analysis (2018-2023)
5.6 UK Psoriasis Sales Revenue Analysis (2018-2023)
5.7 Italy Psoriasis Sales Revenue Analysis (2018-2023)
5.8 Russia Psoriasis Sales Revenue Analysis (2018-2023)
5.9 Spain Psoriasis Sales Revenue Analysis (2018-2023)
5.10 Netherlands Psoriasis Sales Revenue Analysis (2018-2023)
6 Asia Pacific Psoriasis Market Analysis by Countries, Types and End Users
6.1 Asia Pacific Psoriasis Sales Revenue Analysis by Countries (2018-2023)
6.2 Asia Pacific Psoriasis Sales Revenue Analysis by Types (2018-2023)
6.3 Asia Pacific Psoriasis Sales Revenue Analysis by End Users (2018-2023)
6.4 China Psoriasis Sales Revenue Analysis (2018-2023)
6.5 Japan Psoriasis Sales Revenue Analysis (2018-2023)
6.6 Korea Psoriasis Sales Revenue Analysis (2018-2023)
6.7 India Psoriasis Sales Revenue Analysis (2018-2023)
6.8 Australia Psoriasis Sales Revenue Analysis (2018-2023)
6.9 Indonesia Psoriasis Sales Revenue Analysis (2018-2023)
6.10 Vietnam Psoriasis Sales Revenue Analysis (2018-2023)
7 Latin America Psoriasis Market Analysis by Countries, Types and End Users
7.1 Latin America Psoriasis Sales Revenue Analysis by Countries (2018-2023)
7.2 Latin America Psoriasis Sales Revenue Analysis by Types (2018-2023)
7.3 Latin America Psoriasis Sales Revenue Analysis by End Users (2018-2023)
7.4 Brazil Psoriasis Sales Revenue Analysis (2018-2023)
7.5 Mexico Psoriasis Sales Revenue Analysis (2018-2023)
7.6 Argentina Psoriasis Sales Revenue Analysis (2018-2023)
7.7 Colombia Psoriasis Sales Revenue Analysis (2018-2023)
8 Middle East & Africa Psoriasis Market Analysis by Countries, Types and End Users
8.1 Middle East & Africa Psoriasis Sales Revenue Analysis by Countries (2018-2023)
8.2 Middle East & Africa Psoriasis Sales Revenue Analysis by Types (2018-2023)
8.3 Middle East & Africa Psoriasis Sales Revenue Analysis by End Users (2018-2023)
8.4 Turkey Psoriasis Sales Revenue Analysis (2018-2023)
8.5 Saudi Arabia Psoriasis Sales Revenue Analysis (2018-2023)
8.6 South Africa Psoriasis Sales Revenue Analysis (2018-2023)
8.7 Egypt Psoriasis Sales Revenue Analysis (2018-2023)
9 Marketing Channel, Distributors and Traders Analysis
9.1 Marketing Channel
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Distributors and Traders
10 Global Psoriasis Market Forecast by Regions, Countries, Manufacturers, Types and End Users
10.1 Global Sales Revenue Forecast of Psoriasis by Regions (2024-2029)
10.2 Global Sales Revenue Forecast of Psoriasis by Types (2024-2029)
10.3 Global Sales Revenue Forecast of Psoriasis by End Users (2024-2029)
10.4 Global Revenue Forecast of Psoriasis by Countries (2024-2029)
10.4.1 United States Revenue Forecast (2024-2029)
10.4.2 Canada Revenue Forecast (2024-2029)
10.4.3 Germany Revenue Forecast (2024-2029)
10.4.4 France Revenue Forecast (2024-2029)
10.4.5 UK Revenue Forecast (2024-2029)
10.4.6 Italy Revenue Forecast (2024-2029)
10.4.7 Russia Revenue Forecast (2024-2029)
10.4.8 Spain Revenue Forecast (2024-2029)
10.4.9 Netherlands Revenue Forecast (2024-2029)
10.4.10 China Revenue Forecast (2024-2029)
10.4.11 Japan Revenue Forecast (2024-2029)
10.4.12 Korea Revenue Forecast (2024-2029)
10.4.13 India Revenue Forecast (2024-2029)
10.4.14 Australia Revenue Forecast (2024-2029)
10.4.15 Indonesia Revenue Forecast (2024-2029)
10.4.16 Vietnam Revenue Forecast (2024-2029)
10.4.17 Brazil Revenue Forecast (2024-2029)
10.4.18 Mexico Revenue Forecast (2024-2029)
10.4.19 Argentina Revenue Forecast (2024-2029)
10.4.20 Colombia Revenue Forecast (2024-2029)
10.4.21 Turkey Revenue Forecast (2024-2029)
10.4.22 Saudi Arabia Revenue Forecast (2024-2029)
10.4.23 South Africa Revenue Forecast (2024-2029)
10.4.24 Egypt Revenue Forecast (2024-2029)
11 Industry Chain Analysis of Psoriasis
11.1 Upstream Analysis of Psoriasis
11.2 Downstream Major Consumers Analysis of Psoriasis
11.3 Major Suppliers of Psoriasis with Contact Information
11.4 Supply Chain Relationship Analysis of Psoriasis
12 Psoriasis New Project Investment Feasibility Analysis
12.1 Psoriasis New Project SWOT Analysis
12.2 Psoriasis New Project Investment Feasibility Analysis
12.2.1 Project Name
12.2.2 Investment Budget
12.2.3 Project Product Solutions
12.2.4 Project Schedule
13 Psoriasis Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.2 References and Data Sources
14.2.1 Primary Sources
14.2.2 Secondary Paid Sources
14.2.3 Secondary Public Sources
14.3 Abbreviations and Units of Measurement
14.4 Author Details
14.5 Disclaimer
Table Types of Psoriasis
Table End Users of Psoriasis
Figure Market Drivers Analysis of Psoriasis
Figure Market Challenges Analysis of Psoriasis
Figure Market Opportunities Analysis of Psoriasis
Table Market Drivers Analysis of Psoriasis
Table AbbVie Information List
Figure Psoriasis Specifications of AbbVie
Table Psoriasis Revenue (Million USD) and Gross Margin of AbbVie (2018-2023)
Figure Psoriasis Revenue (Million USD) and Global Market Share of AbbVie (2018-2023)
Table Amgen Information List
Figure Psoriasis Specifications of Amgen
Table Psoriasis Revenue (Million USD) and Gross Margin of Amgen (2018-2023)
Figure Psoriasis Revenue (Million USD) and Global Market Share of Amgen (2018-2023)
Table Johnson & Johnson Information List
Figure Psoriasis Specifications of Johnson & Johnson
Table Psoriasis Revenue (Million USD) and Gross Margin of Johnson & Johnson (2018-2023)
Figure Psoriasis Revenue (Million USD) and Global Market Share of Johnson & Johnson (2018-2023)
Table Novartis Information List
Figure Psoriasis Specifications of Novartis
Table Psoriasis Revenue (Million USD) and Gross Margin of Novartis (2018-2023)
Figure Psoriasis Revenue (Million USD) and Global Market Share of Novartis (2018-2023)
Table Eli Lilly & Company Information List
Figure Psoriasis Specifications of Eli Lilly & Company
Table Psoriasis Revenue (Million USD) and Gross Margin of Eli Lilly & Company (2018-2023)
Figure Psoriasis Revenue (Million USD) and Global Market Share of Eli Lilly & Company (2018-2023)
Table AstraZeneca Information List
Figure Psoriasis Specifications of AstraZeneca
Table Psoriasis Revenue (Million USD) and Gross Margin of AstraZeneca (2018-2023)
Figure Psoriasis Revenue (Million USD) and Global Market Share of AstraZeneca (2018-2023)
Table Celgene Corporation Information List
Figure Psoriasis Specifications of Celgene Corporation
Table Psoriasis Revenue (Million USD) and Gross Margin of Celgene Corporation (2018-2023)
Figure Psoriasis Revenue (Million USD) and Global Market Share of Celgene Corporation (2018-2023)
Table UCB Information List
Figure Psoriasis Specifications of UCB
Table Psoriasis Revenue (Million USD) and Gross Margin of UCB (2018-2023)
Figure Psoriasis Revenue (Million USD) and Global Market Share of UCB (2018-2023)
Table Merck Information List
Figure Psoriasis Specifications of Merck
Table Psoriasis Revenue (Million USD) and Gross Margin of Merck (2018-2023)
Figure Psoriasis Revenue (Million USD) and Global Market Share of Merck (2018-2023)
Table Global Revenue (Million USD) of Psoriasis by Regions (2018-2023)
Table Global Revenue (Million USD) of Psoriasis by Manufacturers (2018-2023)
Table Global Revenue (Million USD) of Psoriasis by Types (2018-2023)
Table Global Revenue (Million USD) of Psoriasis by End Users (2018-2023)
Table Northern America Psoriasis Revenue (Million USD) by Countries (2018-2023)
Table Northern America Psoriasis Revenue (Million USD) by Types (2018-2023)
Table Northern America Psoriasis Revenue (Million USD) by End Users (2018-2023)
Figure United States Psoriasis Revenue (Million USD) and Growth Rate (2018-2023)
Figure Canada Psoriasis Revenue (Million USD) and Growth Rate (2018-2023)
Table Europe Psoriasis Revenue (Million USD) by Countries (2018-2023)
Table Europe Psoriasis Revenue (Million USD) by Types (2018-2023)
Table Europe Psoriasis Revenue (Million USD) by End Users (2018-2023)
Figure Germany Psoriasis Revenue (Million USD) and Growth Rate (2018-2023)
Figure France Psoriasis Revenue (Million USD) and Growth Rate (2018-2023)
Figure UK Psoriasis Revenue (Million USD) and Growth Rate (2018-2023)
Figure Italy Psoriasis Revenue (Million USD) and Growth Rate (2018-2023)
Figure Russia Psoriasis Revenue (Million USD) and Growth Rate (2018-2023)
Figure Spain Psoriasis Revenue (Million USD) and Growth Rate (2018-2023)
Figure Netherlands Psoriasis Revenue (Million USD) and Growth Rate (2018-2023)
Table Asia Pacific Psoriasis Revenue (Million USD) by Countries (2018-2023)
Table Asia Pacific Psoriasis Revenue (Million USD) by Types (2018-2023)
Table Asia Pacific Psoriasis Revenue (Million USD) by End Users (2018-2023)
Figure China Psoriasis Revenue (Million USD) and Growth Rate (2018-2023)
Figure Japan Psoriasis Revenue (Million USD) and Growth Rate (2018-2023)
Figure Korea Psoriasis Revenue (Million USD) and Growth Rate (2018-2023)
Figure India Psoriasis Revenue (Million USD) and Growth Rate (2018-2023)
Figure Australia Psoriasis Revenue (Million USD) and Growth Rate (2018-2023)
Figure Indonesia Psoriasis Revenue (Million USD) and Growth Rate (2018-2023)
Figure Vietnam Psoriasis Revenue (Million USD) and Growth Rate (2018-2023)
Table Latin America Psoriasis Revenue (Million USD) by Countries (2018-2023)
Table Latin America Psoriasis Revenue (Million USD) by Types (2018-2023)
Table Latin America Psoriasis Revenue (Million USD) by End Users (2018-2023)
Figure Brazil Psoriasis Revenue (Million USD) and Growth Rate (2018-2023)
Figure Mexico Psoriasis Revenue (Million USD) and Growth Rate (2018-2023)
Figure Argentina Psoriasis Revenue (Million USD) and Growth Rate (2018-2023)
Figure Colombia Psoriasis Revenue (Million USD) and Growth Rate (2018-2023)
Table Middle East & Africa Psoriasis Revenue (Million USD) by Countries (2018-2023)
Table Middle East & Africa Psoriasis Revenue (Million USD) by Types (2018-2023)
Table Middle East & Africa Psoriasis Revenue (Million USD) by End Users (2018-2023)
Figure Turkey Psoriasis Revenue (Million USD) and Growth Rate (2018-2023)
Figure Saudi Arabia Psoriasis Revenue (Million USD) and Growth Rate (2018-2023)
Figure South Africa Psoriasis Revenue (Million USD) and Growth Rate (2018-2023)
Figure Egypt Psoriasis Revenue (Million USD) and Growth Rate (2018-2023)
Table Global Revenue (Million USD) Forecast of Psoriasis by Regions (2024-2029)
Table Global Revenue (Million USD) Forecast of Psoriasis by Types (2024-2029)
Table Global Revenue (Million USD) Forecast of Psoriasis by End Users (2024-2029)
Table Major Consumers with Contact Information of Psoriasis
Table Major Suppliers of Psoriasis with Contact Information
Figure Supply Chain Relationship Analysis of Psoriasis
Table New Project SWOT Analysis of Psoriasis
Table Project Appraisal and Financing
Table New Project Construction Period
Table New Project Investment Feasibility Analysis of Psoriasis
Table Research Programs/Design for This Report
Table Key Data Information from Primary Sources
Table Key Data Information from Secondary Sources
Table Part of Interviewees Record List of Psoriasis Industry
Table Part of References List of Psoriasis Industry
Table Units of Measurement List
Table Part of Author Details List of Psoriasis Industry
HJ Research employs comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecast possible. At HJ Research, our researchers and domain experts use a unique blend of primary and secondary research, with validation and iterations at every stage, in order to minimize deviation and present the most accurate analysis of the Psoriasis industry. Critical elements of methodology employed for all our studies include:
Secondary Sources:
The research team first works with national bureau of statistics, national customs, market research association, state information center, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Secondary sources are mainly from press releases, company reports and publications, non-profit organizations, industry associations, government publications, economic and demographic data and customs data. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Primary Research:
In the primary research process, for comprehensive understanding of the Psoriasis market, it is essential to understand the complete value chain and in order to facilitate this, we collect data from Psoriasis manufacturers, Psoriasis raw material suppliers, Psoriasis distributors as well as buyers. The primary sources from the supply side include Psoriasis manufacturers, opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the Psoriasis raw materials suppliers and producers, etc. The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users, and related key executives from various key companies and organizations operating in the global market.
Technical issues and trends are obtained from surveys, technical symposia and trade journals. Technical data is also gathered from intellectual property perspective, focusing on white space and freedom of movement. Industry dynamics with respect to drivers, restraints, pricing trends are also gathered.
Statistical Model and Data Analysis:
Our market estimates and forecasts are derived through simulation models. A unique model is created customized for each study. Gathered information for market dynamics, technology landscape, application development and pricing trends is fed into the model and analyzed simultaneously. These factors are studied on a comparative basis, and their impact over the forecast period is quantified with the help of correlation, regression and time series analysis. Market forecasting is performed via a combination of economic tools, technological analysis, and industry experience and domain expertise. Qualitative analysis includes: Psoriasis industry landscape and trends, Psoriasis market dynamics and key issues, Psoriasis technology landscape, market opportunities, porter’s analysis and PESTEL analysis, Psoriasis competitive landscape and component benchmarking, policy and regulatory scenario. Quantitative analysis includes: Psoriasis market size and forecast by regions, Psoriasis market size and forecast by application, Psoriasis market size and forecast by types, Psoriasis company market share etc.
Quality Control:
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the HJ Research’s internal quality process.
